182 related articles for article (PubMed ID: 16246548)
41. New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)- and (S)-proline and homologous pyrrolidine-2-alkanoic acids.
Fülep GH; Hoesl CE; Höfner G; Wanner KT
Eur J Med Chem; 2006 Jul; 41(7):809-24. PubMed ID: 16766089
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis, and evaluation of orally active inhibitors of plasminogen activator inhibitor-1 (PAI-1) production.
Miyazaki H; Ogiku T; Sai H; Ohmizu H; Murakami J; Ohtani A
Bioorg Med Chem Lett; 2008 Dec; 18(24):6419-22. PubMed ID: 18993062
[TBL] [Abstract][Full Text] [Related]
43. Development and evaluation of a pharmacophore model for inhibitors of aldosterone synthase (CYP11B2).
Ulmschneider S; Negri M; Voets M; Hartmann RW
Bioorg Med Chem Lett; 2006 Jan; 16(1):25-30. PubMed ID: 16246562
[TBL] [Abstract][Full Text] [Related]
44. Orally active and potent inhibitors of gamma-aminobutyric acid uptake.
Ali FE; Bondinell WE; Dandridge PA; Frazee JS; Garvey E; Girard GR; Kaiser C; Ku TW; Lafferty JJ; Moonsammy GI
J Med Chem; 1985 May; 28(5):653-60. PubMed ID: 2985785
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and anticonvulsant activity of 4-(2-(2,6-dimethylphenylamino)-2-oxoethylamino)-N-(substituted)butanamides: a pharmacophoric hybrid approach.
Yogeeswari P; Sriram D; Sahitya P; Ragavendran JV; Ranganadh V
Bioorg Med Chem Lett; 2007 Jul; 17(13):3712-5. PubMed ID: 17481896
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.
Kragler A; Höfner G; Wanner KT
Eur J Med Chem; 2008 Nov; 43(11):2404-11. PubMed ID: 18395300
[TBL] [Abstract][Full Text] [Related]
47. Kinetic characterization of inhibition of gamma-aminobutyric acid uptake into cultured neurons and astrocytes by 4,4-diphenyl-3-butenyl derivatives of nipecotic acid and guvacine.
Larsson OM; Falch E; Krogsgaard-Larsen P; Schousboe A
J Neurochem; 1988 Mar; 50(3):818-23. PubMed ID: 3339356
[TBL] [Abstract][Full Text] [Related]
48. Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors.
Tang H; Ning FX; Wei YB; Huang SL; Huang ZS; Chan AS; Gu LQ
Bioorg Med Chem Lett; 2007 Jul; 17(13):3765-8. PubMed ID: 17451950
[TBL] [Abstract][Full Text] [Related]
49. Potent agonists of the Hedgehog signaling pathway.
Brunton SA; Stibbard JH; Rubin LL; Guicherit OM; Kruse LI; Price S; di Lucrezia R; MacKinnon CH; Avery A; Park Y; Buxton D; Boyd EA
Bioorg Med Chem Lett; 2009 Aug; 19(15):4308-11. PubMed ID: 19500978
[TBL] [Abstract][Full Text] [Related]
50. Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.
Byun JH; Kim H; Kim Y; Mook-Jung I; Kim DJ; Lee WK; Yoo KH
Bioorg Med Chem Lett; 2008 Oct; 18(20):5591-3. PubMed ID: 18793854
[TBL] [Abstract][Full Text] [Related]
51. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
Sechi M; Rizzi G; Bacchi A; Carcelli M; Rogolino D; Pala N; Sanchez TW; Taheri L; Dayam R; Neamati N
Bioorg Med Chem; 2009 Apr; 17(7):2925-35. PubMed ID: 19026554
[TBL] [Abstract][Full Text] [Related]
52. Matched molecular pair analysis of activity and properties of glycogen phosphorylase inhibitors.
Birch AM; Kenny PW; Simpson I; Whittamore PR
Bioorg Med Chem Lett; 2009 Feb; 19(3):850-3. PubMed ID: 19103484
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
Kim DK; Lim JH; Lee JA; Dewang PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
[TBL] [Abstract][Full Text] [Related]
54. 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Zhan P; Liu X; Cao Y; Wang Y; Pannecouque C; De Clercq E
Bioorg Med Chem Lett; 2008 Oct; 18(20):5368-71. PubMed ID: 18824350
[TBL] [Abstract][Full Text] [Related]
55. Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling.
Zheng M; Zheng M; Ye D; Deng Y; Qiu S; Luo X; Chen K; Liu H; Jiang H
Bioorg Med Chem Lett; 2007 May; 17(9):2414-20. PubMed ID: 17336065
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of analogues of the anti-tumor alkaloid naamidine A.
Aberle N; Catimel J; Nice EC; Watson KG
Bioorg Med Chem Lett; 2007 Jul; 17(13):3741-4. PubMed ID: 17462892
[TBL] [Abstract][Full Text] [Related]
57. Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) delta agonists.
Bratton LD; Filzen GF; Geyer A; Hoffman JK; Lu G; Pulaski J; Trivedi BK; Unangst PC; Xu X
Bioorg Med Chem Lett; 2007 Jul; 17(13):3624-9. PubMed ID: 17498950
[TBL] [Abstract][Full Text] [Related]
58. Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists.
Pingali H; Jain M; Shah S; Makadia P; Zaware P; Goel A; Patel M; Giri S; Patel H; Patel P
Bioorg Med Chem; 2008 Aug; 16(15):7117-27. PubMed ID: 18625559
[TBL] [Abstract][Full Text] [Related]
59. Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors.
Evans KA; Li YH; Coppo FT; Graybill TL; Cichy-Knight M; Patel M; Gale J; Li H; Thrall SH; Tew D; Tavares F; Thomson SA; Weiel JE; Boucheron JA; Clancy DC; Epperly AH; Golden PL
Bioorg Med Chem Lett; 2008 Jul; 18(14):4068-71. PubMed ID: 18554908
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis and structure-activity relationship of simple bis-amides as potent inhibitors of GlyT1.
Jolidon S; Alberati D; Dowle A; Fischer H; Hainzl D; Narquizian R; Norcross R; Pinard E
Bioorg Med Chem Lett; 2008 Oct; 18(20):5533-6. PubMed ID: 18805008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
